Management of Chronic Obstructive Pulmonary Disease in Switzerland
Official title: Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort COPD-Management: Eine Klinisch-epidemiologische Verlaufsbeobachtung in Hausarztpraxen
Run by Cantonal Hospital, Baselland · NCT02065921 · Data updated 2026-11-12
This study looks at how to better manage and treat people with COPD in Switzerland by checking their lung health and smoking history.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 265 (estimated) |
| Sponsor | Cantonal Hospital, Baselland Academic / other |
| Locations | 1 site (Liestal, Basel-Landschaft) |
| Status | Recruiting |
| Started | September 2006 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT02065921 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 40 years old with a history of smoking and diagnosed with COPD characterized by specific lung function criteria.
✕Probably not a fit
Patients under 40 years old or those with a Tiffenau index greater than 70 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort focuses on individuals with Chronic Obstructive Pulmonary Disease (COPD) to improve management and treatment strategies. It aims to systematically diagnose and stratify patients to enhance early detection and prevent disease progression. The study will involve participants who meet specific criteria related to lung function and smoking history, allowing for a better understanding of COPD management in Switzerland.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for COPD, potentially reducing exacerbations and enhancing patient quality of life.
How similar studies have gone: Other studies have shown success in managing COPD through systematic approaches, indicating that this methodology is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Tiffenau (FEV17FVC) \< 70 without reversibility (Increase in FEV1 after inhalation of a bronchodilator \<200 ml and \<12%). * Age: \> 40 years * Both genders * Smokers or ex-smokers of at least 20 pack years. * Informed consent. Exclusion Criteria: * \< 40 Years * Tiffenau (FEV17FVC) \> 70
Where it's running
-
Cantonal Hospital Baselland, Internal medicine University clinic
Liestal, Basel-Landschaft, Switzerland Recruiting
Study contacts
- Study coordinator: Jörg D Leuppi, MD, PhD,Prof.
- Email: joerg.leuppi@ksbl.ch
- Phone: 061 925 2180
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home ventilation for COPD patients
This study is testing if different types of home breathing support can help COPD patients who have trouble breathing after a hospital stay avoid going back to the hospital and live longer.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.